Washington, DC 20006-5349
HELPLINE
Pneumonitis is a serious treatment-related side-effect of both radiation, immunotherapy and some chemotherapies. This episode of MesoTV includes discussion on diagnosis, treatment and the dilemma…
As Father’s Day approaches, many in the meso community will be honoring, and in some cases remembering, the fathers in their lives. In this spirit,…
The National Cancer Institute, part of the National Institutes of Health in Bethesda, Maryland, is working toward developing new protocols for improved treatment for peritoneal…
Peter Liman, 82, is passionate about life. His goal has always been to live life to the fullest. But nine years ago, just as he…
Memorial Day is a time to honor and remember those who have died serving our country. Each year, Eric Linthicum, 62, looks back on his…
Dr. Melissa Johnson of the Sarah Cannon Cancer Center in Nashville, TN talks to us about a multi-center clinical trial utilizing engineered t-cell therapy similar…
Intro Dr. Patrick Forde, MD, is leading the charge in a new clinical trial investigating the effectiveness of immunotherapy in patients who are surgical candidates.…
When it comes to dealing with a mesothelioma diagnosis and its treatment, patients and their physicians are faced with many decisions. Recently, the Mesothelioma Applied…
MesoTV, the informational program by the Mesothelioma Applied Research Foundation, is now available also as a podcast. When unable to watch, patients and their families…
The International Mesothelioma Interest Group (iMig) biannual meeting kicked off in earnest today with its 2021 virtual program. The conference was initially slated to take…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
